18F-FDG Uptake Heterogeneity Predicts Pyrotinib Response

Clinical trial NCT04756921 · COMPLETED

Trial details

NCT number: NCT04756921
Sponsor: Biyun Wang, MD
Status: COMPLETED
Study type: OBSERVATIONAL

HER2-positive Breast Cancer

Start date: 2018-09-01
Primary completion: 2020-07-24
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.